MetAlert, Inc. Stock

Equities

MLRT

US3624083040

Phones & Handheld Devices

Market Closed - OTC Markets 13:11:32 2024-04-26 EDT 5-day change 1st Jan Change
0.0359 USD +3.01% Intraday chart for MetAlert, Inc. -6.27% -22.13%
Sales 2023 * 276B 378B Sales 2024 * 359B 491B Capitalization 1.22M 1.66M
Net income 2023 * -1M -1.37M Net income 2024 * -1M -1.37M EV / Sales 2023 * -
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * -
P/E ratio 2023 *
-0.9 x
P/E ratio 2024 *
-1.2 x
Employees 8
Yield 2023 *
-
Yield 2024 *
-
Free-Float 50.36%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.01%
1 week-6.27%
Current month+12.19%
1 month+3.16%
3 months+2.87%
6 months-59.66%
Current year-22.13%
More quotes
1 week
0.02
Extreme 0.0241
0.04
1 month
0.02
Extreme 0.0232
0.05
Current year
0.02
Extreme 0.016
0.06
1 year
0.02
Extreme 0.016
0.15
3 years
0.02
Extreme 0.016
2.09
5 years
0.02
Extreme 0.016
9.75
10 years
0.02
Extreme 0.016
185.25
More quotes
Managers TitleAgeSince
Founder 74 01-12-31
Chief Executive Officer 60 01-12-31
Director of Finance/CFO 59 11-10-02
Members of the board TitleAgeSince
Chief Executive Officer 60 01-12-31
Founder 74 01-12-31
Director/Board Member 59 10-04-01
More insiders
Date Price Change Volume
24-04-26 0.0359 +3.01% 2,339

Delayed Quote OTC Markets, April 26, 2024 at 01:11 pm

More quotes
Metalert, Inc. is engaged in designing, developing, manufacturing, distributing, selling and licensing products, services and intellectual property in the global positioning system (GPS)/ bluetooth low energy (BLE) wearable technology, personal location, wandering assistive technology, and health data collection and monitoring. The Company offers an end-to-end solution of hardware, software, and connectivity, and develops tracking technologies, which integrate with consumer products and enterprise applications. It utilizes GPS, Cellular, RF, NFC and BLE technology, enabling caregivers to track and monitor patients in real time. The Company’s GPS SmartSole is a wearable technology tracking device created for those at risk of wandering due to Alzheimer's, dementia, autism, and traumatic brain injury. It serves various customers, including the United States military, foreign military, public health authorities and municipalities, first responders, and private schools, among others.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0359 USD
Average target price
0.14 USD
Spread / Average Target
+289.97%
Consensus

Annual profits - Rate of surprise